M any antifungal drugs including the highly successful azoles target the fungal-specific sterol, ergosterol, yet the molecular identity of cellular pathways mediating antifungal activity remained obscure. A recent study on the requirement of ergosterol in vacuolar H + -ATPase (V-ATPase) function uncovered a critical role for ion homeostasis downstream of azole inhibition of ergosterol biosynthesis. Here we review the functional link between regulation of V-ATPase by fungal membrane lipid components and discuss contributions of V-ATPase function to pathogenicity. The importance of pH homeostasis in virulence highlights its potential as target in antifungal chemotherapy.
Sterols are major lipid components in membranes. Besides plasma membrane, where the bulk of sterols reside, sterols have been found in intracellular organelles including peroxisomes, mitochondria, vacuoles/lysosome, ER and trans-Golgi network. The presence of sterols in membranes modulates their thickness, fluidity and permeability. Their preferential association with sphingolipids to form 'raft'-like domains confers membrane heterogeneity and facilitates functions of raftassociated proteins. Fungal cells contain a unique sterol, ergosterol. Deletion of genes responsible for early steps in the ergosterol biosynthetic pathway is lethal, demonstrating that ergosterol plays an essential role in fungal cells. In the battle against pathogenic fungi, ergosterol provides the most common and effective target for several classes of antimycotics, including azoles, allylamines, morpholines and
Beyond ergosterol
Linking pH to antifungal mechanisms vacuolar H + pumping ATPase. Thus, in a genome-wide screen of hypersensitivity to amiodarone, an antifungal agent known to disrupt cellular Ca 2+ and H + homeostasis, we recovered multiple vma and erg mutants. 14 A closer examination revealed that erg mutants as exemplified by erg24D (lacking C-14 sterol reductase), resembled vma mutants in hypersensitivity to Zn 2+ toxicity, inhibitors of the Ca 2+ -activated phosphatase calcineurin (FK506) and a cell wall-disrupting agent (calcofluor white). More significantly, erg mutants exhibited the classical vma phenotype: an inability to grow in alkaline medium, consistent with an inability to acidify the vacuole. Measurement of vacuole pH in situ confirmed that erg mutants failed to acidify vacuoles, essentially indistinguishable from vma mutants lacking a functional H + pump. Finally, purified vacuoles showed severe impairment of H + pumping and ATP hydrolysis rates in erg24D. Taken together, these findings indicated a critical requirement for ergosterol in V-ATPase function. 4 Three classes of antifungals (azoles, morpholines and allylamines) target enzymes catalyzing early reactions in the ergosterol biosynthesis pathway. The most widely used antifungal fluconazole targets the lanosterol demethylase Erg11p, immediately upstream from Erg24p. We found that fluconazole treatment of S. cerevisiae or Candida albicans phenocopied deletion of downstream ERG genes in eliciting vacuolar alkalinization and inhibition of V-ATPase. Strikingly, feeding S. cerevisiae with exogenous ergosterol restored both fungal growth and vacuolar acidification in fluconazole treated cells.
Several lines of evidence suggest direct modulation of V-ATPase by ergosterol. First, ergosterol depletion in erg24D or by fluconazole treatment (20 mg/ml, 6 h) did not alter V-ATPase expression or its localization on vacuolar membrane. 4 Second, ergosterol depletion did not dissociate V 1 and V o domains, a mechanism by which glucose rapidly regulates V-ATPase activity. Upon acute removal of ergosterol from purified vacuolar vesicles by methyl-betacyclodextrin, both V 1 and V 0 domains remained membrane-associated yet V-ATPase activity was lost. Interestingly, V-ATPase subunits exhibited distinct proteolytic patterns following ergosterol extraction, including enhanced degradation of specific fragments and appearance of novel peptide bands (Fig. 1) . This indicates that V-ATPase adopts a different conformation in the absence of ergosterol that may correlate with loss of activity.
Membrane protein function is tightly coupled to membrane lipid composition. Indeed, association of V-ATPase with cholesterol has been documented in mammalian cells 15, 16 and incorporation of cholesterol into membranes stimulated V-ATPase activity in osteoclasts. 17 Phosphatidylinositol phosphates, sphingolipids and cardiolipin have also been reported to regulate V-ATPase function, albeit by distinct mechanisms. In renal epithelial cells, alteration in phosphatidylinositol phosphate composition affected V-ATPase assembly and trafficking. 18 Cardiolipin is located in mitochondrial membrane and its effect on V-ATPase suggests functional cross-talk between vacuoles and mitochondria. 19 The role of sphingolipids in yeast V-ATPase regulation has been characterized in detail. It was shown that depletion of sphingolipids with C26 acyl group disrupted structural integrity of V 1 -V o assembly and disabled V 1 domain function. 20 This is in contrast to our findings that ergosterol depletion did not impair V-ATPase assembly or domain integrity, although it may have altered protein conformation. Thus, although intimately associated in membranes, ergosterol and sphingolipids have distinct effects on protein function. Ergosterol has rigid planar rings whereas sphingolipids display flexible long hydrocarbon chains. This structural difference may dictate their preferential interaction with distinct protein motifs, thereby modulating protein function by different mechanisms.
The importance of the V-ATPase in fungal physiology and virulence cannot be underestimated. The V-ATPase maintains acidic pH within the vacuole to activate lysosomal enzymes for protein processing and degradation, and generates a proton motive force across endomembranes for the transport, sequestration and detoxification of metabolites, ions and drugs. 21, 22 Besides the vacuole, V-ATPase is broadly distributed in the endomembrane system, including the Golgi, secretory vesicles, early and late endosomes 23 where its function is critical for endocytosis, vesicle trafficking, uncoupling of ligand-receptor complexes, and pH-driven exocytosis. Impairment of V-ATPase function, thus, could affect surface expression and secretion of proteins such as superoxide dismutase (Sod5p) and lipases, which play important roles in facilitating infection. 24, 25 In addition, Ca 2+ rich, alkaline serum conditions of the mammalian host present a hostile environment for fungal cells. Defective pH and Ca 2+ -homeostasis would render fungal pathogens susceptible to detrimental ion fluxes encountered in the host. Therefore, disruption of V-ATPase activity downstream from antifungal drug inhibition of ergosterol biosynthesis should cripple multiple cellular functions required for pathogenesis. Indeed, both erg24 -/and vma7 -/null mutants of C. albicans were shown to be avirulent in mouse models of Candidiasis. 26, 27 Thus, while ergosterol depletion may well impact additional cellular targets that remain to be elucidated at a molecular level, loss of V-ATPase function is sufficient to account for loss of virulence.
Another critical consequence of disabling V-ATPase is inhibition of filamentous growth, as was observed for the vma7 -/strain of C. albicans in the presence of serum or liquid Spider medium (with mannitol). 26 Fluconazole treatment and ERG3 deletion have both been shown to inhibit filamentation, 28, 29 which can now be explained, at least in part, due to impaired V-ATPase function. The ability to transition from yeast to hyphae is a critical virulence factor for polymorphic pathogenic fungi, such as C. albicans. 30 To infect their hosts, pathogenic fungi first have to penetrate host epithelial barriers. Once in the bloodstream, fungal cells must survive the attack by macrophages and dendritic cells and subvert innate immune system. A recent report shows that C. albicans cells invade oral and gastrointestinal tractepithelia in hyphal form. 31 Another study shows that wild-type C. albicans cells are more capable than a filamentation-defective mutant (efg1D/cph1D) in blocking phagosomal maturation and acidification. 32 Consistent with these findings, we observe that vma7 -/mutants of C. albicans fail to colonize Caco-2 epithelial models in culture and are efficiently eliminated by murine J774A.1 macrophage cells (Fig. 2) .
Given the significance of filamentation in virulence, the molecular basis underlying the requirement for V-ATPase function in filamentation is a critical area in the study of fungal pathogenesis. The requirement of ergosterol for V-ATPase function suggests that combining azole drugs with other agents that can trigger harmful ion fluxes would have synergistic antifungal effect. The antiarrhythmia drug amiodarone elicits a surge of cytosolic H + and Ca 2+ that triggers ion stress, cell cycle arrest and fungal death, 33, 34 and exhibits synergism with azoles in vitro. 14, 35, 36 We showed that pretreatment with fluconazole exacerbated amiodarone induced H + and Ca 2+ surges in S. cerevisiae and impaired vacuole function in C. albicans. 4 Consistent with increased ion stress from the drug combination, we observed lysis of C. albicans cells in vitro ( Fig. 3 ) and significant reductions in microbial kidney burden in a murine Candidiasis. 35 Maintaining different organelles at distinct pH is critical for multiple cellular events in all eukaryotic cells. The importance of pH homeostasis in fungal pathogenicity is illustrated by the avirulence of V-ATPase null mutants. Future studies of were grown in Dmem with 10% fetal bovine serum to confluence (37ºc, 5% co 2 ). Log phase C. albicans Wt (cNc44) and vma7D/vma7D cells (Vhu4) 26 were inoculated into mammalian cultures at multiplicity of infection of 1/1000 and incubated for 20 hours. Note the inability of vma -/strains to form hyphae and colonize host cells. other proteins involved in ion homeostasis will provide in depth understanding of the role of intracellular ion traffic in specific aspects of pathogenicity, such as secretion of virulence factors, filamentation, biofilm formation, subverting host innate immunity, and adaptation of parasitic life styles. Meanwhile, the success of azole drugs and the realization of their effect on V-ATPase function demonstrate the effectiveness of targeting pH homeostasis in fungal pathogens. The therapeutic potential of combining agents that weaken maintenance of pH homeostasis and those disrupt ion fluxes remain to be further explored in the future.
